由于费用问题,西弗吉尼亚州暂停了对公共雇员的减重药品保险。 West Virginia pauses weight loss drug coverage for public employees due to cost concerns.

西弗吉尼亚州暂停了一个试点方案,涉及1,000名政府雇员的减重药品,因为费用高昂,使病人无法确知他们能否获得药品。 West Virginia has paused a pilot program covering weight loss drugs for 1,000 public employees due to high costs, leaving patients uncertain about their medication access. 公共雇员保险机构(PEIA)仍将为2型糖尿病提供昂贵的GLP-1药物,但不为肥胖症提供药物。 The Public Employee Insurance Agency (PEIA) will still cover the expensive GLP-1 drugs for Type 2 diabetes, but not for obesity. 肥胖症和糖尿病发病率最高的国家担心这一决定可能导致患者健康状况恶化。 The state, with the highest rates of obesity and diabetes, faces concerns that the decision may lead to worsening health outcomes for patients.